Articoli di riviste sul tema "LL-37 peptid"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "LL-37 peptid".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Guo, Fang-Fang, e Jing-Yuan Fang. "Antimicrobial peptide LL-37 and gastrointestinal diseases". World Chinese Journal of Digestology 22, n. 35 (2014): 5454. http://dx.doi.org/10.11569/wcjd.v22.i35.5454.
Bucki, Robert, Katarzyna Leszczyńska, Andrzej Namiot e Wojciech Sokołowski. "Cathelicidin LL-37: A Multitask Antimicrobial Peptide". Archivum Immunologiae et Therapiae Experimentalis 58, n. 1 (5 gennaio 2010): 15–25. http://dx.doi.org/10.1007/s00005-009-0057-2.
Rapala-Kozik, Maria, Oliwia Bochenska, Marcin Zawrotniak, Natalia Wolak, Grzegorz Trebacz, Mariusz Gogol, Dominika Ostrowska, Wataru Aoki, Mitsuyoshi Ueda e Andrzej Kozik. "Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans". Infection and Immunity 83, n. 6 (6 aprile 2015): 2518–30. http://dx.doi.org/10.1128/iai.00023-15.
Sieprawska-Lupa, Magdalena, Piotr Mydel, Katarzyna Krawczyk, Kinga Wójcik, Magdalena Puklo, Boguslaw Lupa, Piotr Suder et al. "Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases". Antimicrobial Agents and Chemotherapy 48, n. 12 (dicembre 2004): 4673–79. http://dx.doi.org/10.1128/aac.48.12.4673-4679.2004.
Martynowycz, Michael, Amy Rice, Konstantin Andreev, Thatyane M. Nobre Pavinatto, Jeff Wereszczynski e David Gidalevitz. "Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides". Biophysical Journal 116, n. 3 (febbraio 2019): 45a. http://dx.doi.org/10.1016/j.bpj.2018.11.285.
Yusuf, Muhammad, Wanda Destiarani, Ade Rizqi Ridwan Firdaus, Fauzian Giansyah Rohmatulloh, Mia Tria Novianti, Gita Widya Pradini e Reiva Farah Dwiyana. "Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by All-Atom Molecular Dynamics Simulation". International Journal of Molecular Sciences 23, n. 21 (2 novembre 2022): 13413. http://dx.doi.org/10.3390/ijms232113413.
Zhao, Chengquan, Tung Nguyen, Lee Ming Boo, Teresa Hong, Cesar Espiritu, Dmitri Orlov, Wei Wang, Alan Waring e Robert I. Lehrer. "RL-37, an Alpha-Helical Antimicrobial Peptide of the Rhesus Monkey". Antimicrobial Agents and Chemotherapy 45, n. 10 (1 ottobre 2001): 2695–702. http://dx.doi.org/10.1128/aac.45.10.2695-2702.2001.
Bals, Robert, Xiaorong Wang, Michael Zasloff e James M. Wilson. "The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface". Proceedings of the National Academy of Sciences 95, n. 16 (4 agosto 1998): 9541–46. http://dx.doi.org/10.1073/pnas.95.16.9541.
Ishvaanjil, Bayartbat, Yu-Jin Jung, Uyangaa Temuujin, Soon-Youl Lee e Kwon-Kyoo Kang. "HETEROLOGOUS EXPRESSION OF ANTIMICROBIAL PEPTIDE LL-37 IN CHINESE CABBAGE WITH ENHANCED RESISTANCE TO PATHOGENS". Mongolian Journal of Agricultural Sciences 13, n. 2 (22 giugno 2015): 124–30. http://dx.doi.org/10.5564/mjas.v13i2.531.
Ridyard, Kylen E., e Joerg Overhage. "The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent". Antibiotics 10, n. 6 (29 maggio 2021): 650. http://dx.doi.org/10.3390/antibiotics10060650.
Rinker, Sherri D., Michael P. Trombley, Xiaoping Gu, Kate R. Fortney e Margaret E. Bauer. "Deletion ofmtrCin Haemophilus ducreyi Increases Sensitivity to Human Antimicrobial Peptides and Activates the CpxRA Regulon". Infection and Immunity 79, n. 6 (28 marzo 2011): 2324–34. http://dx.doi.org/10.1128/iai.01316-10.
Qin, G. T., A. Lopez, C. Santos, A. M. McDermott e C. Z. Cai. "Antimicrobial peptide LL-37 on surfaces presenting carboxylate anions". Biomaterials Science 3, n. 5 (2015): 771–78. http://dx.doi.org/10.1039/c5bm00055f.
Torossian, Alexander, Eugeniu Gurschi, Robert Bals, Timon Vassiliou, Hinnerk F. Wulf e Artur Bauhofer. "Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats". Anesthesiology 107, n. 3 (1 settembre 2007): 437–41. http://dx.doi.org/10.1097/01.anes.0000278906.86815.eb.
Perez-Perez, David A., Teresa de J. Villanueva-Ramirez, Adriana E. Hernandez-Pedraza, Nestor G. Casillas-Vega, Patricia Gonzalez-Barranco e Xristo Zarate. "The Small Metal-Binding Protein SmbP Simplifies the Recombinant Expression and Purification of the Antimicrobial Peptide LL-37". Antibiotics 10, n. 10 (19 ottobre 2021): 1271. http://dx.doi.org/10.3390/antibiotics10101271.
McCrudden, Maelíosa, Katherine O’Donnell, Chris Irwin e Fionnuala Lundy. "Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?" Vaccines 6, n. 3 (23 luglio 2018): 44. http://dx.doi.org/10.3390/vaccines6030044.
Sigurdardottir, Thorgerdur, Pia Andersson, Mina Davoudi, Martin Malmsten, Artur Schmidtchen e Mikael Bodelsson. "In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37". Antimicrobial Agents and Chemotherapy 50, n. 9 (settembre 2006): 2983–89. http://dx.doi.org/10.1128/aac.01583-05.
Yang, De, Qian Chen, Albert P. Schmidt, G. Mark Anderson, Ji Ming Wang, Joseph Wooters, Joost J. Oppenheim e Oleg Chertov. "Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells". Journal of Experimental Medicine 192, n. 7 (2 ottobre 2000): 1069–74. http://dx.doi.org/10.1084/jem.192.7.1069.
Byfield, Fitzroy J., Qi Wen, Katarzyna Leszczyńska, Alina Kułakowska, Zbigniew Namiot, Paul A. Janmey e Robert Bucki. "Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability". American Journal of Physiology-Cell Physiology 300, n. 1 (gennaio 2011): C105—C112. http://dx.doi.org/10.1152/ajpcell.00158.2010.
Peter Bergman, Lilian Walter-Jallow, Kristina Broliden, Birgitta Agerberth e Johan Soderlund. "The Antimicrobial Peptide LL-37 Inhibits HIV-1 Replication". Current HIV Research 5, n. 4 (1 luglio 2007): 410–15. http://dx.doi.org/10.2174/157016207781023947.
Supanchart, C., S. Thawanaphong, A. Makeudom, J. G. Bolscher, K. Nazmi, U. Kornak e S. Krisanaprakornkit. "The Antimicrobial Peptide, LL-37, Inhibits in vitro Osteoclastogenesis". Journal of Dental Research 91, n. 11 (13 settembre 2012): 1071–77. http://dx.doi.org/10.1177/0022034512460402.
Srakaew, Nopparat, Charlene Young, Krista Quesnel, Hongbin Xu, Riccardo di Brisco, Duriya Fongmoon, Greanggrai Hommalai et al. "Antimicrobial Peptide, LL-37, as a Potential Vaginal Contraceptive." Biology of Reproduction 87, Suppl_1 (1 agosto 2012): 357. http://dx.doi.org/10.1093/biolreprod/87.s1.357.
Fabisiak, Adam, Natalia Murawska e Jakub Fichna. "LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity". Pharmacological Reports 68, n. 4 (agosto 2016): 802–8. http://dx.doi.org/10.1016/j.pharep.2016.03.015.
Lee, Chang-Chun, Yen Sun, Chih-Wei Chen, Shuo Qian e Huey W. Huang. "Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37". Biophysical Journal 100, n. 3 (febbraio 2011): 336a. http://dx.doi.org/10.1016/j.bpj.2010.12.2039.
Lee, Chang-Chun, Yen Sun, Shuo Qian e Huey W. Huang. "Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37". Biophysical Journal 100, n. 7 (aprile 2011): 1688–96. http://dx.doi.org/10.1016/j.bpj.2011.02.018.
Lee, Moonhee, Xiaolei Shi, Annelise E. Barron, Edith McGeer e Patrick L. McGeer. "Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation". Biochemical Pharmacology 94, n. 2 (marzo 2015): 130–41. http://dx.doi.org/10.1016/j.bcp.2015.02.003.
Zsila, Ferenc, e Tamás Beke-Somfai. "Human host-defense peptide LL-37 targets stealth siderophores". Biochemical and Biophysical Research Communications 526, n. 3 (giugno 2020): 780–85. http://dx.doi.org/10.1016/j.bbrc.2020.03.162.
Nagant, C., B. Pitts, K. Nazmi, M. Vandenbranden, J. G. Bolscher, P. S. Stewart e J. P. Dehaye. "Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments". Antimicrobial Agents and Chemotherapy 56, n. 11 (20 agosto 2012): 5698–708. http://dx.doi.org/10.1128/aac.00918-12.
Hitchon, Carol A., Xiaobo Meng, Hani S. El Gabalawy e Linda Larcombe. "Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis". RMD Open 5, n. 1 (aprile 2019): e000874. http://dx.doi.org/10.1136/rmdopen-2018-000874.
Chen, Xi, Xianqiong Zou, Guangying Qi, Ying Tang, Yong Guo, Jia Si e Lihua Liang. "Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer". Cellular Physiology and Biochemistry 47, n. 3 (2018): 1060–73. http://dx.doi.org/10.1159/000490183.
Turner, Jeffrey, Yoon Cho, Nhu-Nguyen Dinh, Alan J. Waring e Robert I. Lehrer. "Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils". Antimicrobial Agents and Chemotherapy 42, n. 9 (1 settembre 1998): 2206–14. http://dx.doi.org/10.1128/aac.42.9.2206.
Deshpande, Dhruva, Mark Grieshober, Fanny Wondany, Fabian Gerbl, Reiner Noschka, Jens Michaelis e Steffen Stenger. "Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37". International Journal of Molecular Sciences 21, n. 18 (14 settembre 2020): 6741. http://dx.doi.org/10.3390/ijms21186741.
Chawla, Himika, Parmita Kar, Soma Saha, Urvashi B. Singh, Nikhil Tandon e Goswami R. "Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control". Annals of the National Academy of Medical Sciences (India) 53, n. 02 (aprile 2017): 066–72. http://dx.doi.org/10.1055/s-0040-1712747.
Raqib, Rubhana, Anna Ly, Evana Akhtar, Akhirunnesa Mily, Nandita Perumal, Abdullah Al-Mahmud, Rokeya Sultana Rekha, Abdullah Hel Baqui e Daniel E. Roth. "Prenatal vitamin D3supplementation suppresses LL-37 peptide expression inex vivoactivated neonatal macrophages but not their killing capacity". British Journal of Nutrition 112, n. 6 (4 agosto 2014): 908–15. http://dx.doi.org/10.1017/s0007114514001512.
Kumagai, Yumi, Taisuke Murakami, Kuwahara-Arai, Toshiaki Iba, Johannes Reich e Isao Nagaoka. "Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils". Innate Immunity 26, n. 7 (29 giugno 2020): 565–79. http://dx.doi.org/10.1177/1753425920936754.
Lau, Y. Elaine, Annett Rozek, Monisha G. Scott, Danika L. Goosney, Donald J. Davidson e Robert E. W. Hancock. "Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells". Infection and Immunity 73, n. 1 (gennaio 2005): 583–91. http://dx.doi.org/10.1128/iai.73.1.583-591.2005.
Shaykhiev, Renat, Christoph Beißwenger, Kerstin Kändler, Judith Senske, Annette Püchner, Thomas Damm, Jürgen Behr e Robert Bals. "Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure". American Journal of Physiology-Lung Cellular and Molecular Physiology 289, n. 5 (novembre 2005): L842—L848. http://dx.doi.org/10.1152/ajplung.00286.2004.
Overhage, Joerg, Andrea Campisano, Manjeet Bains, Ellen C. W. Torfs, Bernd H. A. Rehm e Robert E. W. Hancock. "Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation". Infection and Immunity 76, n. 9 (30 giugno 2008): 4176–82. http://dx.doi.org/10.1128/iai.00318-08.
Rosen, Graciela, Michael N. Sela e Gilad Bachrach. "The Antibacterial Activity of LL-37 against Treponema denticola Is Dentilisin Protease Independent and Facilitated by the Major Outer Sheath Protein Virulence Factor". Infection and Immunity 80, n. 3 (19 dicembre 2011): 1107–14. http://dx.doi.org/10.1128/iai.05903-11.
Noore, Jabeen, Adly Noore e Bingyun Li. "Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus". Antimicrobial Agents and Chemotherapy 57, n. 3 (28 dicembre 2012): 1283–90. http://dx.doi.org/10.1128/aac.01650-12.
Yason, John Anthony, Sitara Swarna Rao Ajjampur e Kevin Shyong Wei Tan. "Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37". Infection and Immunity 84, n. 8 (23 maggio 2016): 2220–32. http://dx.doi.org/10.1128/iai.00339-16.
Tripathi, Shweta, Tesfaldet Tecle, Anamika Verma, Erika Crouch, Mitchell White e Kevan L. Hartshorn. "The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins". Journal of General Virology 94, n. 1 (1 gennaio 2013): 40–49. http://dx.doi.org/10.1099/vir.0.045013-0.
OREN, Ziv, Jeffrey C. LERMAN, Gudmundur H. GUDMUNDSSON, Birgitta AGERBERTH e Yechiel SHAI. "Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity". Biochemical Journal 341, n. 3 (26 luglio 1999): 501–13. http://dx.doi.org/10.1042/bj3410501.
Jones, Allison, Miriam Geörg, Lisa Maudsdotter e Ann-Beth Jonsson. "Endotoxin, Capsule, and Bacterial Attachment Contribute to Neisseria meningitidis Resistance to the Human Antimicrobial Peptide LL-37". Journal of Bacteriology 191, n. 12 (17 aprile 2009): 3861–68. http://dx.doi.org/10.1128/jb.01313-08.
Johansson, Linda, Pontus Thulin, Parham Sendi, Erika Hertzén, Adam Linder, Per Åkesson, Donald E. Low, Birgitta Agerberth e Anna Norrby-Teglund. "Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans". Infection and Immunity 76, n. 8 (19 maggio 2008): 3399–404. http://dx.doi.org/10.1128/iai.01392-07.
Nagaoka, Isao, Hiroshi Tamura e Johannes Reich. "Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model". International Journal of Molecular Sciences 21, n. 17 (19 agosto 2020): 5973. http://dx.doi.org/10.3390/ijms21175973.
Zeth, Kornelius, e Enea Sancho-Vaello. "Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures". International Journal of Molecular Sciences 22, n. 10 (14 maggio 2021): 5200. http://dx.doi.org/10.3390/ijms22105200.
Hase, Koji, Lars Eckmann, John D. Leopard, Nissi Varki e Martin F. Kagnoff. "Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium". Infection and Immunity 70, n. 2 (febbraio 2002): 953–063. http://dx.doi.org/10.1128/iai.70.2.953-963.2002.
Bryzek, Danuta, Anna Golda, Joanna Budziaszek, Dominik Kowalczyk, Alicia Wong, Ewa Bielecka, Priyanka Shakamuri et al. "Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity". International Journal of Molecular Sciences 21, n. 23 (30 novembre 2020): 9126. http://dx.doi.org/10.3390/ijms21239126.
Björstad, Åse, Galia Askarieh, Kelly L. Brown, Karin Christenson, Huamei Forsman, Karin Önnheim, Hsin-Ni Li et al. "The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes". Antimicrobial Agents and Chemotherapy 53, n. 3 (15 dicembre 2008): 1027–38. http://dx.doi.org/10.1128/aac.01310-08.
Zhang, Yingxia, Jayaram Lakshmaiah Narayana, Qianhui Wu, Xiangli Dang e Guangshun Wang. "Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37". Pharmaceuticals 14, n. 12 (30 novembre 2021): 1245. http://dx.doi.org/10.3390/ph14121245.